Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

BMJ (Clinical research ed.)

Volumn 355, Issue , 2016, Pages i4924-

  Dijkstra, Maaike G ^a   van Zummeren, Marjolein ^a   Rozendaal, Lawrence ^a   van Kemenade, Folkert J ^a   Helmerhorst, Theo J M ^a   Snijders, Peter J F ^a   Meijer, Chris J L M ^a   Berkhof, Johannes ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AFTERCARE; AGE; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; NETHERLANDS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TIME FACTOR; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADENOCARCINOMA; ADULT; AFTERCARE; AGE FACTORS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 85011955622     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4924     Document Type: Article

References (0)